Art

J-GLOBAL ID：201902258919332927   Reference number：19A1781085

Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats

経強膜移植可能デバイスを用いた経強膜持続性ラニビズマブ送達:ラットにおけるレーザ誘発脈絡膜血管新生の抑制【JST・京大機械翻訳】

Author (11)： Nagai Nobuhiro (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Nezhad Zhaleh Kashkouli (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Daigaku Reiko (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Saijo Saaya (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Song Yuanhui (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Terata Keiko (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Hoshi Ayako (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan) ,  Nishizawa Matsuhiko (Department of Finemechanics, Graduate School of Engineering, Tohoku University, 6-6-01 Aramaki, Aoba-ku, Sendai 980-8579, Japan) ,  Nakazawa Toru (Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan) ,  Kaji Hirokazu (Department of Finemechanics, Graduate School of Engineering, Tohoku University, 6-6-01 Aramaki, Aoba-ku, Sendai 980-8579, Japan) ,  Abe Toshiaki (Division of Clinical Cell Therapy, United Centers for Advanced Research and Translational Medicine (ART), Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan)
Material： International Journal of Pharmaceutics  (Int J Pharm)
Volume： 567  Page： Null  Publication year： 2019 
JST Material Number： A0285B  ISSN： 0378-5173  CODEN： IJPHD  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Successful treatment of age-re...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1781085&from=J-GLOBAL&jstjournalNo=A0285B") }}

Thesaurus term： gel ,  gelatin ,  in vitro experiment ,  collagen ,  effectiveness ,  human(primates) ,  retina ,  *laser ,  *rat ,  administration route ,  *sclera ,  albumin
Semi thesaurus term： 徐放 ,  *ラニビズマブ ,  *持続性 , 【Automatic Indexing@JST】

Author keywords (6)： Drug delivery system ,  Polyethylene glycol dimethacrylate ,  Retina ,  Transscleral delivery ,  Age-related macular disease ,  Choroidal neovascularization

JST classification (1)： Basic biopharmacy  (GY01021U)

Terms in the title (9)： 強膜 ,  移植 ,  持続性 ,  ラニビズマブ ,  送達 ,  ラット ,  レーザ ,  誘発 ,  脈絡膜血管新生